Special report: maintenance therapy in advanced non-small-cell lung cancer
BlueCross BlueShield Association
Record ID 32011000435
English
Authors' objectives:
The purpose of this Special Report is to survey the literature on the use of maintenance therapy to improve outcomes in patients being treated with first-line platinum doublet therapy for advanced NSCLC. Special attention will be directed to the recent introduction of new molecularly targeted treatments. Endpoints evaluated will include progression-free survival, overall survival, toxicity and, when available, information on quality of life.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.bcbs.com/blueresources/tec/vols/26/26_4.pdf
URL for additional information:
http://www.bcbs.com/blueresources/tec/vols/26/maintenance-therapy.html
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Lung Neoplasms
- Molecular Targeted Therapy
Contact
Organisation Name:
BlueCross BlueShield Association
Contact Address:
BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
tec@bcbsa.com
Contact Email:
tec@bcbsa.com
Copyright:
BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.